Abstract
321 ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT I. Mederacke, C. Yurdaydin, B. Bremer, Y. Cakaloglu, A. Erhardt, K. Yalcin, K. Zachou, S. Gurel, B. Heidrich, G. Dalekos, H.P. Dienes, M.P. Manns, H. Wedemeyer. Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany; University of Ankara Medical School, Gastroenterology Section, Ankara, Istanbul Medical School, Gastroenterohepatology Section, Istanbul University, Istanbul, Turkey; Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine University, Duesseldorf, Germany; Division of Hepatology, Dicle University School of Medicine, Diyarbakir, Turkey; Internal Medicine, Medical School, University of Thessaly, Larissa, Greece; Gastroenterology Section, Uludag University Medical School, Bursa, Turkey; Institute of Pathology, University of Cologne, Cologne, Germany E-mail: mederacke.ingmar@mh-hannover.de
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
